J. Degregori, The genetics of the E2F family of transcription factors: shared functions and unique roles, Biochim Biophys Acta, vol.1602, issue.2, pp.131-50, 2002.

N. Dyson, The regulation of E2F by pRB-family proteins, Genes Dev, vol.12, issue.15, pp.2245-62, 1998.

D. Stefano, L. Jensen, M. R. Helin, and K. , E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes, Embo J, vol.22, issue.23, pp.6289-98, 2003.

J. W. Harbour and D. C. Dean, The Rb/E2F pathway: expanding roles and emerging paradigms, Genes Dev, vol.14, pp.2393-409, 2000.

J. Degregori, G. Leone, A. Miron, L. Jakoi, and J. R. Nevins, Distinct roles for E2F proteins in cell growth control and apoptosis, Proc Natl Acad Sci U S A, vol.94, issue.14, pp.7245-50, 1997.

D. G. Johnson, J. K. Schwarz, W. D. Cress, and J. R. Nevins, Expression of transcription factor E2F1 induces quiescent cells to enter S phase, Nature, vol.365, issue.6444, pp.349-52, 1993.

X. Q. Qin, D. M. Livingston, W. G. Kaelin, J. Adams, and P. D. , Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis, Proc Natl Acad Sci, vol.91, issue.23, pp.10918-10940, 1994.

X. Wu and A. J. Levine, p53 and E2F-1 cooperate to mediate apoptosis, Proc Natl Acad Sci U S A, vol.91, issue.9, pp.3602-3608, 1994.

T. F. Kowalik, J. Degregori, G. Leone, L. Jakoi, and J. R. Nevins, E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2, Cell Growth Differ, vol.9, issue.2, pp.113-121, 1998.

S. J. Field, F. Y. Tsai, F. Kuo, A. M. Zubiaga, W. G. Kaelin et al., , pp.2-3

, functions in mice to promote apoptosis and suppress proliferation, Cell, vol.85, issue.4, pp.549-61, 1996.

I. Garcia, M. Murga, A. Vicario, S. J. Field, and A. M. Zubiaga, A role for E2F1 in the induction of apoptosis during thymic negative selection, Cell Growth Differ, vol.11, issue.2, pp.91-99, 2000.

L. Yamasaki, T. Jacks, R. Bronson, E. Goillot, E. Harlow et al., Tumor induction and tissue atrophy in mice lacking E2F-1, Cell, vol.85, issue.4, pp.537-585, 1996.

S. W. Hiebert, G. Packham, D. K. Strom, R. Haffner, M. Oren et al., E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis, Mol Cell Biol, vol.15, issue.12, pp.6864-74, 1995.

J. K. Hsieh, S. Fredersdorf, T. Kouzarides, K. Martin, and X. Lu, E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction, Genes Dev, vol.11, issue.14, pp.1840-52, 1997.

D. Ginsberg, E2F1 pathways to apoptosis, FEBS Lett, vol.529, issue.1, pp.122-127, 2002.

Q. Cao, Y. Xia, M. Azadniv, and I. N. Crispe, The E2F-1 transcription factor promotes caspase-8 and bid expression, and enhances Fas signaling in T cells, J Immunol, vol.173, issue.2, pp.1111-1118, 2004.

S. T. Hou, X. Xie, A. Baggley, D. S. Park, G. Chen et al.,

, pathway by the nonproliferative p38 MAPK during Fas (APO1/CD95)-mediated neuronal apoptosis, J Biol Chem, vol.277, issue.50, pp.48764-70, 2002.

N. Itoh, S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima et al., The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis, Cell, vol.66, issue.2, pp.233-276, 1991.

M. P. Boldin, E. E. Varfolomeev, Z. Pancer, I. L. Mett, J. H. Camonis et al., A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain, J Biol Chem, vol.270, issue.14, pp.7795-7803, 1995.

A. M. Chinnaiyan, K. O'rourke, M. Tewari, and V. M. Dixit, FADD, a novel death domaincontaining protein, interacts with the death domain of Fas and initiates apoptosis, Cell, vol.81, issue.4, pp.505-517, 1995.

M. P. Boldin, T. M. Goncharov, Y. V. Goltsev, and D. Wallach, Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death, Cell, vol.85, issue.6, pp.803-818, 1996.

S. M. Srinivasula, M. Ahmad, T. Fernandes-alnemri, G. Litwack, and E. S. Alnemri, Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases, Proc Natl Acad Sci, vol.93, issue.25, pp.14486-91, 1996.

M. Muzio, A. M. Chinnaiyan, F. C. Kischkel, K. O'rourke, A. Shevchenko et al.,

, FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex, Cell, vol.85, issue.6, pp.817-844, 1996.

F. C. Kischkel, S. Hellbardt, I. Behrmann, M. Germer, M. Pawlita et al.,

, Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor, Embo J, vol.14, issue.22, pp.5579-88, 1995.

J. P. Medema, C. Scaffidi, F. C. Kischkel, A. Shevchenko, M. Mann et al.,

, FLICE is activated by association with the CD95 death-inducing signaling complex (DISC)

, Embo J, vol.16, issue.10, pp.2794-804, 1997.

H. Hirata, A. Takahashi, S. Kobayashi, S. Yonehara, H. Sawai et al., Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis, J Exp Med, 1998.

C. Scaffidi, S. Fulda, A. Srinivasan, C. Friesen, F. Li et al., Two CD95 (APO-1/Fas) signaling pathways, Embo J, vol.17, issue.6, pp.1675-87, 1998.

Y. V. Goltsev, A. V. Kovalenko, A. E. Varfolomeev, E. E. Brodianskii, V. M. et al.,

D. Cash, a novel caspase homologue with death effector domains, J Biol Chem, vol.272, issue.32, pp.19641-19645, 1997.

D. K. Han, P. M. Chaudhary, M. E. Wright, C. Friedman, B. J. Trask et al., MRIT, a novel death-effector domain-containing protein, interacts with caspases and BclXL and initiates cell death, Proc Natl Acad Sci U S A, vol.94, issue.21, pp.11333-11341, 1997.

S. Hu, C. Vincenz, J. Ni, R. Gentz, V. M. Dixit et al., CLARP, a death effector domaincontaining protein interacts with caspase-8 and regulates apoptosis, Proc Natl Acad Sci U S A, vol.272, issue.28, pp.10717-10739, 1997.

M. Irmler, M. Thome, M. Hahne, P. Schneider, K. Hofmann et al., Inhibition of death receptor signals by cellular FLIP, Nature, vol.388, issue.6638, pp.190-195, 1997.

H. B. Shu, D. R. Halpin, and D. V. Goeddel, Casper is a FADD-and caspase-related inducer of apoptosis, Immunity, vol.6, issue.6, pp.751-63, 1997.

S. M. Srinivasula, M. Ahmad, S. Ottilie, F. Bullrich, S. Banks et al., FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis, J Biol Chem, vol.272, issue.30, pp.18542-18547, 1997.

A. Krueger, I. Schmitz, S. Baumann, P. H. Krammer, and S. Kirchhoff, Cellular FLICEinhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex, J Biol Chem, vol.276, issue.23, pp.20633-20673, 2001.

D. W. Chang, Z. Xing, Y. Pan, A. Algeciras-schimnich, B. C. Barnhart et al., c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis, Embo J, vol.21, issue.14, pp.3704-3718, 2002.

O. Micheau, M. Thome, P. Schneider, N. Holler, J. Tschopp et al., The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex, J Biol Chem, vol.277, issue.47, pp.45162-71, 2002.

K. M. Boatright, C. Deis, J. B. Denault, D. P. Sutherlin, and G. S. Salvesen, Activation of caspases-8 and -10 by FLIP(L), Biochem J, vol.382, issue.2, pp.651-658, 2004.

S. Mathas, A. Lietz, I. Anagnostopoulos, F. Hummel, B. Wiesner et al., c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis, J Exp Med, vol.199, issue.8, pp.1041-52, 2004.

B. Eymin, S. Gazzeri, C. Brambilla, and E. Brambilla, Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma, Oncogene, vol.20, issue.14, pp.1678-87, 2001.
URL : https://hal.archives-ouvertes.fr/inserm-02337591

A. C. Phillips, S. Bates, K. M. Ryan, K. Helin, and K. H. Vousden, Induction of DNA synthesis and apoptosis are separable functions of E2F-1, Genes Dev, vol.11, issue.14, pp.1853-63, 1997.

Z. Nahle, J. Polakoff, R. V. Davuluri, M. E. Mccurrach, M. D. Jacobson et al.,

, Direct coupling of the cell cycle and cell death machinery by E2F, Nat Cell Biol, vol.4, issue.11, pp.859-64, 2002.

S. Fulda, C. Friesen, M. Los, C. Scaffidi, W. Mier et al., Betulinic acid triggers CD95 (APO-1/Fas)-and p53-independent apoptosis via activation of caspases in neuroectodermal tumors, Cancer Res, vol.57, issue.21, pp.4956-64, 1997.

Y. Aragane, D. Kulms, D. Metze, G. Wilkes, B. Poppelmann et al., Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L, J Cell Biol, 1998.

J. G. Boesen-de-cock, E. De-vries, G. T. Williams, and J. Borst, The anti-cancer drug etoposide

O. Micheau, E. Solary, A. Hammann, and M. T. Dimanche-boitrel, Fas ligand-independent

, FADD-mediated activation of the Fas death pathway by anticancer drugs, J Biol Chem, vol.274, issue.12, pp.7987-92, 1999.

A. Algeciras-schimnich, L. Shen, B. C. Barnhart, A. E. Murmann, J. K. Burkhardt et al., Molecular ordering of the initial signaling events of CD95, Mol Cell Biol, vol.22, issue.1, pp.207-227, 2002.

D. Kagi, F. Vignaux, B. Ledermann, K. Burki, V. Depraetere et al., Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity, Science, vol.265, issue.5171, pp.528-558, 1994.

B. Lowin, M. Hahne, C. Mattmann, and J. Tschopp, Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways, Nature, vol.370, issue.6491, pp.650-652, 1994.

F. Mami-chouaib, H. Echchakir, D. G. Vergnon, I. Chouaib, and S. , Antitumor cytotoxic T-lymphocyte response in human lung carcinoma: identification of a tumorassociated antigen, Immunol Rev, vol.188, pp.114-135, 2002.

M. Djerbi, V. Screpanti, A. I. Catrina, B. Bogen, P. Biberfeld et al., The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors, J Exp Med, vol.190, issue.7, pp.1025-1057, 1999.

J. P. Medema, J. De-jong, T. Van-hall, C. J. Melief, and R. Offringa, Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein, J Exp Med, vol.190, issue.7, pp.1033-1041, 1999.

M. Irwin, M. C. Marin, A. C. Phillips, R. S. Seelan, D. I. Smith et al., Role for the p53 homologue p73 in E2F-1-induced apoptosis, Nature, vol.407, issue.6804, pp.645-653, 2000.

T. Stiewe and B. M. Putzer, Role of the p53-homologue p73 in E2F1-induced apoptosis, Nat Genet, vol.26, issue.4, pp.464-473, 2000.

M. C. Moroni, E. S. Hickman, E. L. Denchi, G. Caprara, E. Colli et al., Apaf-1 is a transcriptional target for E2F and p53, Nat Cell Biol, vol.3, issue.6, pp.552-560, 2001.

Y. Furukawa, N. Nishimura, M. Satoh, H. Endo, S. Iwase et al., Apaf-1 is a mediator of E2F-1-induced apoptosis, J Biol Chem, vol.277, issue.42, pp.39760-39768, 2002.

A. C. Phillips, M. K. Ernst, S. Bates, N. R. Rice, and K. H. Vousden, E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways, Mol Cell, vol.4, issue.5, pp.771-81, 1999.

S. Wang, N. Nath, A. Minden, and S. Chellappan, Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases, Embo J, vol.18, issue.6, pp.1559-70, 1999.

B. Bi, N. K. Littlewood, and I. N. Crispe, Cleavage of E2F-1-regulating proteins and activation of E2F-1 during CD95-induced death of thymocytes, Immunology, vol.104, issue.1, pp.37-42, 2001.

J. Tschopp, M. Irmler, and M. Thome, Inhibition of fas death signals by FLIPs, Curr Opin Immunol, vol.10, issue.5, pp.552-560, 1998.

Y. Jiang, W. N. Rom, T. A. Yie, C. X. Chi, and K. M. Tchou-wong, Induction of tumor suppression and glandular differentiation of A549 lung carcinoma cells by dominant-negative IGF-I receptor, Oncogene, vol.18, issue.44, pp.6071-6078, 1999.

S. Fulda, E. Meyer, and K. M. Debatin, Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression, Cancer Res, vol.60, issue.14, pp.3947-56, 2000.

M. Thome, P. Schneider, K. Hofmann, H. Fickenscher, E. Meinl et al., Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors, Nature, vol.386, issue.6624, pp.517-538, 1997.

L. Bin, X. Li, L. G. Xu, and H. B. Shu, The short splice form of Casper/c-FLIP is a major cellular inhibitor of TRAIL-induced apoptosis, FEBS Lett, vol.510, issue.1-2, pp.37-40, 2002.

S. Kirchhoff, W. W. Muller, A. Krueger, I. Schmitz, and P. H. Krammer, TCR-mediated upregulation of c-FLIPshort correlates with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity, J Immunol, vol.165, issue.11, pp.6293-300, 2000.

J. H. Lieman, L. A. Worley, and J. W. Harbour, Loss of Rb-E2F repression results in caspase-8

T. Fukazawa, T. Fujiwara, F. Uno, F. Teraishi, Y. Kadowaki et al., mediated apoptosis through inactivation of focal adhesion kinase, J Biol Chem, vol.67, 2005.

, Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells, Oncogene, vol.20, issue.37, pp.5225-5256, 2001.

Y. Kim, N. Suh, M. Sporn, and J. C. Reed, An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis, J Biol Chem, vol.277, issue.25, pp.22320-22329, 2002.

M. S. Ricci, J. Z. Dews, M. Yu, D. Thomas-tikhonenko, A. Dicker et al., Direct repression of FLIP expression by c-myc is a major determinant of TRAIL sensitivity, Mol Cell Biol, vol.24, issue.19, pp.8541-55, 2004.

H. Tanaka, I. Matsumura, S. Ezoe, Y. Satoh, T. Sakamaki et al.,

, Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSODmediated ROS elimination, Mol Cell, vol.9, issue.5, pp.1017-1046, 2002.

O. Micheau, S. Lens, O. Gaide, K. Alevizopoulos, and J. Tschopp, NF-kappaB signals induce the expression of c-FLIP, Mol Cell Biol, vol.21, issue.16, pp.5299-305, 2001.

T. F. Burns and W. S. El-deiry, Identification of inhibitors of TRAIL-induced death (ITIDs)

, in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approach, J Biol Chem, vol.276, issue.41, 2001.

I. Schmitz, H. Weyd, A. Krueger, S. Baumann, S. C. Fas et al., Resistance of short term activated T cells to CD95-mediated apoptosis correlates with de novo protein synthesis of c-FLIP(short), J Immunol, vol.172, issue.4, pp.2194-200, 2004.

L. E. French and J. Tschopp, Defective death receptor signaling as a cause of tumor immune escape, Semin Cancer Biol, vol.12, issue.1, pp.51-56, 2002.

W. Roth, S. Isenmann, M. Nakamura, M. Platten, W. Wick et al., Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis, Cancer Res, vol.61, issue.6, pp.2759-65, 2001.

M. Hahne, D. Rimoldi, M. Schroter, P. Romero, M. Schreier et al., Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape, Science, vol.274, issue.5291, pp.1363-1369, 1996.

C. S. Mitsiades, N. Mitsiades, V. Poulaki, R. Schlossman, M. Akiyama et al.,

, Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF

, Akt signaling in human multiple myeloma cells: therapeutic implications, Oncogene, vol.21, issue.37, pp.5673-83, 2002.

I. Viard-leveugle, S. Veyrenc, L. E. French, C. Brambilla, and E. Brambilla,

, Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma, J Pathol, vol.201, issue.2, pp.268-77, 2003.

B. Eymin, C. Leduc, J. L. Coll, E. Brambilla, and S. Gazzeri, p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice, Oncogene, vol.22, issue.12, pp.1822-1857, 2003.

J. Plumas, M. C. Jacob, L. Chaperot, J. P. Molens, J. J. Sotto et al., Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosis, Blood, vol.91, issue.8, pp.2875-85, 1998.

, Western blot analysis of E2F1 and c-FLIP expression in 5 representative adenocarcinoma lung tumor (T) and their matched normal lung (N)